Keeping the biotechnology of antisense in context
- 1 March 1999
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 17 (3), 209
- https://doi.org/10.1038/6909
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Anti-tumor activity of C-raf antisense--correction.Nature Medicine, 1999
- Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotidesNucleic Acids Research, 1998
- Tetranucleotide GGGA Motif in Primary RNA TranscriptsPublished by Elsevier ,1998
- Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotideNucleic Acids Research, 1997
- Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotidesProceedings of the National Academy of Sciences, 1997
- Bias in Nucleotide Composition of Antisense OligonucleotidesAntisense and Nucleic Acid Drug Development, 1996
- Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cellsNucleic Acids Research, 1995
- Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular MatrixPublished by Elsevier ,1995
- Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.Journal of Biological Chemistry, 1994
- Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.Journal of Biological Chemistry, 1992